1-es típusú cukorbetegség: vizsgálatok itt: Katar

1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

• 4. fázisNot yet taking people in Katar
  Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?

  Where

  Doha

  Életkor

  18 év and over

  People

  60 worldwide

  Run by

  Dasman Diabetes Institute

  See details and how to joinNCT06922656